[Therapeutic targets in arterial hypertension and diabetes mellitus. Can medical prevention be harmful?].

Der Internist
C ChatzikyrkouJ Menne

Abstract

Arterial hypertension contributes considerably to the increased cardiorenal risk of patients with diabetes mellitus type 2. Therefore guideline-writing authorities recommend starting antihypertensive treatment generously, with the aim of reducing blood pressure to levels to < 130/80 mmHg. Nevertheless, results of several recent studies have challenged the currently prevailing paradigm "the lower the better" in hypertension management. A similar paradigm also seems to hold true for the management of blood glucose in these patients. Detailed analyses have shown an increased risk of coronary events by targeting both lower blood pressure and blood glucose levels, especially in those with established cardiovascular disease and especially coronary artery disease--thus, the concept of "the lower the better" should be reconsidered in this group of patients.

References

Jul 16, 2003·Archives of Internal Medicine·George L BakrisUNKNOWN RENAAL Study Group
Dec 6, 2003·Hypertension·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jun 3, 2005·Journal of the American Society of Nephrology : JASN·Tomas BerlUNKNOWN Collaborative Study Group
Apr 10, 2008·JAMA : the Journal of the American Medical Association·Barbara V HowardJianhui Zhu
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanDavid R Matthews
Dec 19, 2008·The New England Journal of Medicine·William DuckworthUNKNOWN VADT Investigators
Feb 20, 2009·Journal of the American Society of Nephrology : JASN·Bastiaan E de GalanUNKNOWN ADVANCE Collaborative Group
May 16, 2009·Journal of the American Society of Nephrology : JASN·Toshiharu NinomiyaUNKNOWN ADVANCE Collaborative Group
Oct 20, 2009·Journal of Hypertension·Giuseppe ManciaUNKNOWN European Society of Hypertension
Mar 17, 2010·The New England Journal of Medicine·William C CushmanFaramarz Ismail-Beigi
May 27, 2010·European Heart Journal·Hiddo J Lambers HeerspinkUNKNOWN ADVANCE Collaborative Group
Jul 8, 2010·JAMA : the Journal of the American Medical Association·Rhonda M Cooper-DeHoffCarl J Pepine
Aug 21, 2010·Current Hypertension Reports·Matthew R Weir, George L Bakris
Sep 8, 2010·The New England Journal of Medicine·Lawrence J AppelUNKNOWN AASK Collaborative Research Group
Sep 18, 2010·European Heart Journal·Sripal BangaloreUNKNOWN Treating to New Targets Steering Committee and Investigators
Oct 12, 2010·The New England Journal of Medicine·Sophia ZoungasUNKNOWN ADVANCE Collaborative Group
Nov 10, 2010·Diabetes Care·Robert J AndersonUNKNOWN VADT Study Group
Mar 3, 2011·JAMA : the Journal of the American Medical Association·Angela M ThompsonLydia A Bazzano
Mar 11, 2011·The New England Journal of Medicine·Hermann HallerUNKNOWN ROADMAP Trial Investigators
Mar 16, 2011·Annals of Internal Medicine·Ashish UpadhyayKatrin Uhlig
Sep 10, 2011·Current Hypertension Reports·Colleen Flynn, George L Bakris
Sep 17, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Rebecca HanrattyJohn F Steiner
Nov 10, 2011·Hypertension·Johannes A N DorresteijnUNKNOWN Secondary Manifestations of Arterial Disease Study Group

❮ Previous
Next ❯

Citations

Feb 14, 2014·The European Journal of General Practice·Tomasz TomasikJacek Jozwiak
Oct 27, 2017·MMW Fortschritte der Medizin·Kristian Rett

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.